However, despite an absence of the well-characterized V600E mutation, BRAF mutations in our MTC cohort occurred in two non-hotspot sites G469A and T599dup, suggesting novel drivers in this cancer. Here, BRAF is linked to medullary thyroid gland carcinoma.